Skip to content

Clinical trials

Phase 3 Anxiety Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Phase 3 Clear all

145 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20022
20035
200411
200512
200617
20073
200813
20098
20108
20116
20128
20136
20141
20154
20163
20173
20181
20191
20202
20215
20222
20233
20243
20252
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed104
Unknown status13
Terminated9
Recruiting8
Active, not recruiting5
Not yet recruiting3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi8
Eli Lilly and Company7
AstraZeneca6
Otsuka Pharmaceutical Development & Commercialization, Inc.6
Karolinska Institutet5
Takeda4
Massachusetts General Hospital3
University of Pennsylvania3
Alliance for Clinical Trials in Oncology2
Cephalon2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders145
Generalized Anxiety Disorder31
Phobia, Social13
Stress Disorders, Post-Traumatic12
Pain9
Major Depressive Disorder6
Mental Disorders6
Panic Disorder5
Stress Disorders, Traumatic5
Breast Neoplasms4

Trials

Showing 76 to 100 of 145. Each trial links to its page on Pharma Observatory.

45 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.